Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

GSDME promotes MASLD by regulating pyroptosis, Drp1 citrullination-dependent mitochondrial dynamic, and energy balance in intestine and liver

Cell Death & Differentiation (2024)Cite this article

Subjects

Abstract

Dysregulated metabolism, cell death, and inflammation contribute to the development of metabolic dysfunction-associated steatohepatitis (MASH). Pyroptosis, a recently identified form of programmed cell death, is closely linked to inflammation. However, the precise role of pyroptosis, particularly gasdermin-E (GSDME), in MASH development remains unknown. In this study, we observed GSDME cleavage and GSDME-associated interleukin-1β (IL-1β)/IL-18 induction in liver tissues of MASH patients and MASH mouse models induced by a choline-deficient high-fat diet (CDHFD) or a high-fat/high-cholesterol diet (HFHC). Compared with wild-type mice, global GSDME knockout mice exhibited reduced liver steatosis, steatohepatitis, fibrosis, endoplasmic reticulum stress, lipotoxicity and mitochondrial dysfunction in CDHFD- or HFHC-induced MASH models. Moreover, GSDME knockout resulted in increased energy expenditure, inhibited intestinal nutrient absorption, and reduced body weight. In the mice with GSDME deficiency, reintroduction of GSDME in myeloid cells—rather than hepatocytes—mimicked the MASH pathologies and metabolic dysfunctions, as well as the changes in the formation of neutrophil extracellular traps and hepatic macrophage/monocyte subclusters. These subclusters included shifts in Tim4+ or CD163+ resident Kupffer cells, Ly6Chi pro-inflammatory monocytes, and Ly6CloCCR2loCX3CR1hi patrolling monocytes. Integrated analyses of RNA sequencing and quantitative proteomics revealed a significant GSDME-dependent reduction in citrullination at the arginine-114 (R114) site of dynamin-related protein 1 (Drp1) during MASH. Mutation of Drp1 at R114 reduced its stability, impaired its ability to redistribute to mitochondria and regulate mitophagy, and ultimately promoted its degradation under MASH stress. GSDME deficiency reversed the de-citrullination of Drp1R114, preserved Drp1 stability, and enhanced mitochondrial function. Our study highlights the role of GSDME in promoting MASH through regulating pyroptosis, Drp1 citrullination-dependent mitochondrial function, and energy balance in the intestine and liver, and suggests that GSDME may be a potential therapeutic target for managing MASH.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Hepatic GSDME expression in MASH patients and mice.
Fig. 2: Global knockout of GSDME ameliorates steatosis and steatohepatitis in CDHFD-induced MASH mouse model.
Fig. 3: Global Knockout of GSDME mitigates liver fibrosis, ER stress and mitochondrial dysfunction in CDHFD-induced MASH mouse model.
Fig. 4: Impacts of rescuing GSDME gene transcription in different liver cell types on MASH development.
Fig. 5: Multiplexed Flow Cytometry Reveals the Regulatory Action of Myeloid GSDME on MΦ/MO Infiltration In MASH.
Fig. 6: GSDME controls energy homeostasis and intentisne nutrition absorption.
Fig. 7: MASH Promotes Loss of Drp1 R114 Citrullination, Which Is Reversed by GSDME Deletion.
Fig. 8: R114 Citrullination of Drp1 Is Critical for Its Stability and Mitochondrial Function.

Similar content being viewed by others

Data availability

The Raw RNA-sequencing data was deposited in NCBI Sequence Read Archive (SRA) database (No. PRJNA1004734). The raw proteomic data was deposited in PRoteomics IDEntifications (PRIDE) database (No. PXD044559). Other data analyzed during this study are included in this published article and the Supplementary data files. Additional supporting data are available from the corresponding authors upon reasonable request.

References

  1. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–56.

    Article  PubMed  CAS  Google Scholar 

  2. Krag A, Buti M, Lazarus JV, Allen AM, Bowman J, Burra P, et al. Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives. J Hepatol. 2023;79:1076–8.

    Article  PubMed  Google Scholar 

  3. Peiseler M, Schwabe R, Hampe J, Kubes P, Heikenwalder M, Tacke F. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. J Hepatol. 2022;77:1136–60.

    Article  PubMed  CAS  Google Scholar 

  4. Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature. 1992;358:167–9.

    Article  PubMed  CAS  Google Scholar 

  5. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481:278–86.

    Article  PubMed  CAS  Google Scholar 

  6. Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660–5.

    Article  PubMed  CAS  Google Scholar 

  7. Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666–71.

    Article  PubMed  CAS  Google Scholar 

  8. Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017;8:14128.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99–103.

    Article  PubMed  CAS  Google Scholar 

  10. Zhang J, Yu Q, Jiang D, Yu K, Yu W, Chi Z, et al. Epithelial Gasdermin D shapes the host-microbial interface by driving mucus layer formation. Sci Immunol. 2022;7:eabk2092.

    Article  PubMed  CAS  Google Scholar 

  11. Tan G, Huang C, Chen J, Chen B, Zhi F. Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn’s disease by promoting intestinal inflammation. Cell Rep. 2021;35:109265.

    Article  PubMed  CAS  Google Scholar 

  12. Xu B, Jiang M, Chu Y, Wang W, Chen D, Li X, et al. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. J Hepatol. 2018;68:773–82.

    Article  PubMed  CAS  Google Scholar 

  13. Yang C, Sun P, Deng M, Loughran P, Li W, Yi Z, et al. Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis. Cell Death Dis. 2019;10:481.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Liu F, Ghimire L, Balasubramanian A, Hsu AY, Zhang Z, Yu H, et al. Neutrophil-specific depletion of gasdermin D does not protect against murine sepsis. Blood. 2023;141:550–4.

    Article  PubMed  CAS  Google Scholar 

  15. Ma EB, Javaid HMA, Jung DH, Park JH, Huh JY. Gasdermin D Deficiency Does Not Protect Mice from High-Fat Diet-Induced Glucose Intolerance and Adipose Tissue Inflammation. Mediators Inflamm. 2022;2022:7853482.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kambara H, Liu F, Zhang X, Liu P, Bajrami B, Teng Y, et al. Gasdermin D Exerts Anti-inflammatory Effects by Promoting Neutrophil Death. Cell Rep. 2018;22:2924–36.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Chen T, Meng Y, Zhou Z, Li H, Wan L, Kang A, et al. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis. Cell Death Differ. 2023;30:1829–48.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Dragatsis I, Zeitlin S. A method for the generation of conditional gene repair mutations in mice. Nucleic Acids Res. 2001;29:E10.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Guilliams M, Scott CL. Liver macrophages in health and disease. Immunity. 2022;55:1515–29.

    Article  PubMed  CAS  Google Scholar 

  20. Tran S, Baba I, Poupel L, Dussaud S, Moreau M, Gelineau A, et al. Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis. Immunity. 2020;53:627–40.e625.

    Article  PubMed  CAS  Google Scholar 

  21. van der Windt DJ, Sud V, Zhang H, Varley PR, Goswami J, Yazdani HO, et al. Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis. Hepatology. 2018;68:1347–60.

    Article  PubMed  Google Scholar 

  22. Yu K, Proost P. Insights into peptidylarginine deiminase expression and citrullination pathways. Trends Cell Biol. 2022;32:746–61.

    Article  PubMed  CAS  Google Scholar 

  23. Rosdah AA, Smiles WJ, Oakhill JS, Scott JW, Langendorf CG, Delbridge LMD, et al. New perspectives on the role of Drp1 isoforms in regulating mitochondrial pathophysiology. Pharm Ther. 2020;213:107594.

    Article  CAS  Google Scholar 

  24. Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007;8:939–44.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Prudent J, Zunino R, Sugiura A, Mattie S, Shore GC, McBride HM. MAPL SUMOylation of Drp1 Stabilizes an ER/Mitochondrial Platform Required for Cell Death. Mol Cell. 2015;59:941–55.

    Article  PubMed  CAS  Google Scholar 

  26. Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458:1131–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. de Carvalho Ribeiro M, Szabo G. Role of the Inflammasome in Liver Disease. Annu Rev Pathol. 2022;17:345–65.

    Article  PubMed  Google Scholar 

  28. Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, et al. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. J Hepatol. 2021;74:156–67.

    Article  PubMed  CAS  Google Scholar 

  29. Chai Q, Yu S, Zhong Y, Lu Z, Qiu C, Yu Y, et al. A bacterial phospholipid phosphatase inhibits host pyroptosis by hijacking ubiquitin. Science. 2022;378:eabq0132.

    Article  PubMed  CAS  Google Scholar 

  30. Luchetti G, Roncaioli JL, Chavez RA, Schubert AF, Kofoed EM, Reja R, et al. Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection. Cell Host Microbe. 2021;29:1521–30.e1510.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Weindel CG, Martinez EL, Zhao X, Mabry CJ, Bell SL, Vail KJ, et al. Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. Cell. 2022;185:3214–31.e3223.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Aki T, Funakoshi T, Unuma K, Uemura K. Inverse regulation of GSDMD and GSDME gene expression during LPS-induced pyroptosis in RAW264.7 macrophage cells. Apoptosis. 2022;27:14–21.

    Article  PubMed  CAS  Google Scholar 

  33. Deng W, Bai Y, Deng F, Pan Y, Mei S, Zheng Z, et al. Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis. Nature. 2022;602:496–502.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Zhou Z, He, H, Wang, K, Shi, X, Wang, Y, Su, Y, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368:eaaz7548.

  35. Oltra SS, Colomo S, Sin L, Perez-Lopez M, Lazaro S, Molina-Crespo A, et al. Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells. Cell Death Differ. 2023;30:1366–81.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Li X, Zhang T, Kang L, Xin R, Sun M, Chen Q, et al. Apoptotic caspase-7 activation inhibits non-canonical pyroptosis by GSDMB cleavage. Cell Death Differ. 2023;30:2120–34.

    Article  PubMed  CAS  Google Scholar 

  37. Zhang X, Luo S, Wang M, Cao Q, Zhang Z, Huang Q, et al. Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation. Nat Commun. 2022;13:7582.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. Chen Q, Shi P, Wang D, Liu Q, Li X, Wang Y, et al. Epidermis-Activated Gasdermin-A3 Enhances Thermogenesis of Brown Adipose Tissue through IL-6/Stat3 Signaling. Am J Pathol. 2019;189:1041–52.

    Article  PubMed  CAS  Google Scholar 

  39. Rosina M, Ceci V, Turchi R, Chuan L, Borcherding N, Sciarretta F, et al. Ejection of damaged mitochondria and their removal by macrophages ensure efficient thermogenesis in brown adipose tissue. Cell Metab. 2022;34:533–48.e512.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. He K, Wan T, Wang D, Hu J, Zhou T, Tao W, et al. Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine. Cell. 2023;186:3033–3048 e3020.

    Article  PubMed  Google Scholar 

  41. Rana N, Privitera G, Kondolf HC, Bulek K, Lechuga S, De Salvo C, et al. GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis. Cell. 2022;185:283–98.e217.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  42. Xi R, Montague, J, Lin, X, Lu, C, Lei, W, Tanaka, K, et al. Up-regulation of gasdermin C in mouse small intestine is associated with lytic cell death in enterocytes in worm-induced type 2 immunity. Proc Natl Acad Sci USA. 2021;118:e2026307118.

  43. Steffen J, Ngo J, Wang SP, Williams K, Kramer HF, Ho G, et al. The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR. Mol Metab. 2022;64:101566.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Wang L, Ishihara T, Ibayashi Y, Tatsushima K, Setoyama D, Hanada Y, et al. Disruption of mitochondrial fission in the liver protects mice from diet-induced obesity and metabolic deterioration. Diabetologia. 2015;58:2371–80.

    Article  PubMed  CAS  Google Scholar 

  45. Kim KH, Kim SH, Han DH, Jo YS, Lee YH, Lee MS. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice. Sci Rep. 2018;8:6789.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Zhang Z, Xu X, Tian W, Jiang R, Lu Y, Sun Q, et al. ARRB1 inhibits non-alcoholic steatohepatitis progression by promoting GDF15 maturation. J Hepatol. 2020;72:976–89.

    Article  PubMed  CAS  Google Scholar 

  47. Loomba R, Sanyal AJ, Kowdley KV, Bhatt DL, Alkhouri N, Frias JP, et al. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH. N Engl J Med. 2023;389:998–1008.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Li H, Fang Q, Gao F, Fan J, Zhou J, Wang X, et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol. 2010;53:934–40.

    Article  PubMed  CAS  Google Scholar 

  49. Yahoo N, Dudek M, Knolle P, Heikenwalder M. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. J Hepatol. 2023;79:538–51.

    Article  PubMed  CAS  Google Scholar 

  50. Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, et al. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation. Sci Immunol. 2021;6:eabj3859.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Chen KW, Demarco, B, Ramos, S, Heilig, R, Goris, M, Grayczyk, JP, et al. RIPK1 activates distinct gasdermins in macrophages and neutrophils upon pathogen blockade of innate immune signaling. Proc Natl Acad Sci USA. 2021;118:e2101189118.

  52. Singh J, Boettcher M, Dolling M, Heuer A, Hohberger B, Leppkes M, et al. Moonlighting chromatin: when DNA escapes nuclear control. Cell Death Differ. 2023;30:861–75.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  53. Yang ML, Horstman S, Gee R, Guyer P, Lam TT, Kanyo J, et al. Citrullination of glucokinase is linked to autoimmune diabetes. Nat Commun. 2022;13:1870.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019;10:1689.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Neel DV, Basu H, Gunner G, Bergstresser MD, Giadone RM, Chung H, et al. Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. Neuron. 2023;111:1222–40.e1229.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Vringer E, Tait SWG. Mitochondria and cell death-associated inflammation. Cell Death Differ. 2023;30:304–12.

    Article  PubMed  CAS  Google Scholar 

  57. Rappold PM, Cui M, Grima JC, Fan RZ, de Mesy-Bentley KL, Chen L, et al. Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo. Nat Commun. 2014;5:5244.

    Article  PubMed  CAS  Google Scholar 

  58. Qi X, Qvit N, Su YC, Mochly-Rosen D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci. 2013;126:789–802.

    PubMed  PubMed Central  CAS  Google Scholar 

  59. Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol. 2023;78:415–29.

    Article  PubMed  CAS  Google Scholar 

  60. Linden D, Romeo S. Therapeutic opportunities for the treatment of NASH with genetically validated targets. J Hepatol. 2023;79:1056–64.

    Article  PubMed  CAS  Google Scholar 

  61. Ma X, Chen A, Melo L, Clemente-Sanchez A, Chao X, Ahmadi AR, et al. Loss of hepatic DRP1 exacerbates alcoholic hepatitis by inducing megamitochondria and mitochondrial maladaptation. Hepatology. 2023;77:159–75.

    Article  PubMed  Google Scholar 

  62. Tong M, Mukai R, Mareedu S, Zhai P, Oka SI, Huang CY, et al. Distinct Roles of DRP1 in Conventional and Alternative Mitophagy in Obesity Cardiomyopathy. Circ Res. 2023;133:6–21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  63. Hong X, Isern J, Campanario S, Perdiguero E, Ramirez-Pardo I, Segales J, et al. Mitochondrial dynamics maintain muscle stem cell regenerative competence throughout adult life by regulating metabolism and mitophagy. Cell Stem Cell. 2022;29:1298–1314.e1210.

    Article  PubMed  CAS  Google Scholar 

  64. Ngo J, Choi DW, Stanley IA, Stiles L, Molina AJA, Chen PH, et al. Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl-CoA. EMBO J. 2023;42:e111901.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  65. Moore MP, Cunningham RP, Meers GM, Johnson SA, Wheeler AA, Ganga RR, et al. Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. Hepatology. 2022;76:1452–65.

    Article  PubMed  CAS  Google Scholar 

  66. Sainero-Alcolado L, Liano-Pons J, Ruiz-Perez MV, Arsenian-Henriksson M. Targeting mitochondrial metabolism for precision medicine in cancer. Cell Death Differ. 2022;29:1304–17.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Xiong X, Hasani S, Young LEA, Rivas DR, Skaggs AT, Martinez R, et al. Activation of Drp1 promotes fatty acids-induced metabolic reprograming to potentiate Wnt signaling in colon cancer. Cell Death Differ. 2022;29:1913–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  68. Ouyang SX, Zhu JH, Cao Q, Liu J, Zhang Z, Zhang Y, et al. Gasdermin-E-Dependent Non-Canonical Pyroptosis Promotes Drug-Induced Liver Failure by Promoting CPS1 deISGylation and Degradation. Adv Sci. 2024;11:e2305715.

    Article  Google Scholar 

  69. Wang L, Zhu L, Liang C, Huang X, Liu Z, Huo J, et al. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis. J Hepatol. 2023;79:1185–1200.

    Article  PubMed  CAS  Google Scholar 

  70. Liu D, Zhang P, Zhou J, Liao R, Che Y, Gao MM, et al. TNFAIP3 Interacting Protein 3 Overexpression Suppresses Nonalcoholic Steatohepatitis by Blocking TAK1 Activation. Cell Metab. 2020;31:726–40.e728.

    Article  PubMed  CAS  Google Scholar 

  71. Fu JT, Liu, J, Wu, WB, Chen, YT, Lu, GD, Cao, Q, et al. Targeting EFHD2 Inhibits Interferon-gamma Signaling and Ameliorates Non-Alcoholic Steatohepatitis. J Hepatol. 2024; https://doi.org/10.1016/j.jhep.2024.1004.1009.

  72. Cao HJ, Jiang H, Ding K, Qiu XS, Ma N, Zhang FK, et al. ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2. Cell Death Differ. 2023;30:383–96.

    Article  PubMed  CAS  Google Scholar 

  73. Ji QX, Zeng FY, Zhou J, Wu WB, Wang XJ, Zhang Z, et al. Ferroptotic stress facilitates smooth muscle cell dedifferentiation in arterial remodelling by disrupting mitochondrial homeostasis. Cell Death Differ. 2023;30:457–74.

    Article  PubMed  CAS  Google Scholar 

  74. Chi C, Fu H, Li YH, Zhang GY, Zeng FY, Ji QX, et al. Exerkine fibronectin type-III domain-containing protein 5/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability. Eur Heart J. 2022;43:4579–95.

    Article  PubMed  CAS  Google Scholar 

  75. Werner M, Driftmann S, Kleinehr K, Kaiser GM, Mathe Z, Treckmann JW, et al. All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells. PLoS One. 2015;10:e0138655.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Sun DY, Wu WB, Wu JJ, Shi Y, Xu JJ, Ouyang SX, et al. Pro-ferroptotic signaling promotes arterial aging via vascular smooth muscle cell senescence. Nat Commun. 2024;15:1429.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  77. Tong J, Li D, Meng H, Sun D, Lan X, Ni M, et al. Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease. Acta Pharm Sin B. 2022;12:3650–66.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  78. Yang J, Chen S, Huang L, Michalopoulos GK, Liu Y. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. Hepatology. 2001;33:848–59.

    Article  PubMed  CAS  Google Scholar 

  79. Liu J, Huang X, Werner M, Broering R, Yang D, Lu M. Advanced Method for Isolation of Mouse Hepatocytes, Liver Sinusoidal Endothelial Cells, and Kupffer Cells. Methods Mol Biol. 2017;1540:249–58.

    Article  PubMed  CAS  Google Scholar 

  80. Heiberger R, Robbins N. Design of diverging stacked bar charts for Likert scales and other applications. J Stat Softw. 2014;57:1–32.

    Article  Google Scholar 

Download references

Funding

This work was supported by the grants from National Natural Science Foundation of China (82073915, 82373927, 82274030 and 8210453), Shanghai Science and Technology Commission (21XD1424900, 19140904700, 19140904900, 2019CXJQ03 and 21S11901200), Shanghai Shuguang Program (19SG32), Shanghai Municipal Three Year Action Plan for Strengthening the Construction of Public Health System (GWVI-11.2-XD06) and Outstanding Youth in Shanghai Skin Hospital (202172). We thank the patients and their families.

Author information

Author notes

  1. These authors contributed equally: Jia-Hui Zhu, Shen-Xi Ouyang, Guo-Yan Zhang, Qi Cao, Rujuan Xin.

Authors and Affiliations

  1. Department of Pharmacy, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

    Jia-Hui Zhu, Shen-Xi Ouyang, Guo-Yan Zhang, Hang Yin, Jing-Wen Wu, Yan Zhang, Zhen Zhang, Yi Liu, Jie Tong, Fu-Ming Shen & Dong-Jie Li

  2. Department of Clinical Research, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China

    Jia-Hui Zhu, Jiang-Tao Fu, Yi-Ting Chen & Jia-Bao Zhang

  3. The Center for Basic Research and Innovation of Medicine and Pharmacy (MOE), School of Pharmacy, Naval Medical University, Shanghai, China

    Qi Cao, Jia-Bao Zhang & Pei Wang

  4. The National Demonstration Center for Experimental Pharmaceutical Education, Naval Medical University, Shanghai, China

    Qi Cao & Pei Wang

  5. Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China

    Rujuan Xin

  6. Department of Hepatic Surgery, The Eastern Hepatobiliary Surgery Hospital, Naval Medical University/Second Military Medical University, Shanghai, China

    Jian Liu

Authors
  1. Jia-Hui Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shen-Xi Ouyang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guo-Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qi Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rujuan Xin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hang Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jing-Wen Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yi Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jiang-Tao Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yi-Ting Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jie Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jia-Bao Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Fu-Ming Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Dong-Jie Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Pei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PW conceived and designed research; JHZ, SXO, QC, GYZ, JWW, YZ, JT, ZZ, YL, JTF, and HY performed experiments; JL provided patents samples; YTC, JT, HBZ, DJL and FMS analyzed data. JHZ, SXO, QC and PW wrote the manuscript. PW and JBZ provided funding. All authors contributed with productive discussions and knowledge to the final version of this manuscript.

Corresponding author

Correspondence to Pei Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

The ethical aspects for the human samples were reviewed and approved by the institutional research ethics committee of the Eastern Hepatobiliary Surgery Hospital (approval number: EHBHKY2020-K-045). The research was conducted in accordance with the ethical principles of the Helsinki Declaration. Informed consent was duly obtained from each participant included in the study. For the animal study, all experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Shanghai Tenth People’s Hospital of Tongji University (approval number: SHDSYY-2022-3019) and followed the Principles of Laboratory Animal Care published by the National Institutes of Health (NIH publication 86-23 revised 1985) and ARRIVE guidelines.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, JH., Ouyang, SX., Zhang, GY. et al. GSDME promotes MASLD by regulating pyroptosis, Drp1 citrullination-dependent mitochondrial dynamic, and energy balance in intestine and liver. Cell Death Differ (2024). https://doi.org/10.1038/s41418-024-01343-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41418-024-01343-0

Search

Advanced search

Quick links